RFA
Resurgent Financial Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $527K | Sell |
2,841
-17
| -0.6% | -$3.16K | 0.29% | 102 |
|
|
2025
Q1 | $599K | Sell |
2,858
-393
| -12% | -$82.3K | 0.36% | 77 |
|
|
2024
Q4 | $578K | Buy |
3,251
+42
| +1% | +$7.46K | 0.34% | 87 |
|
|
2024
Q3 | $634K | Buy |
3,209
+598
| +23% | +$118K | 0.37% | 79 |
|
|
2024
Q2 | $448K | Buy |
2,611
+57
| +2% | +$9.78K | 0.28% | 109 |
|
|
2024
Q1 | $465K | Sell |
2,554
-100
| -4% | -$18.2K | 0.25% | 111 |
|
|
2023
Q4 | $411K | Sell |
2,654
-454
| -15% | -$70.4K | 0.25% | 104 |
|
|
2023
Q3 | $463K | Buy |
3,108
+7
| +0.2% | +$1.04K | 0.32% | 82 |
|
|
2023
Q2 | $418K | Buy |
3,101
+147
| +5% | +$19.8K | 0.28% | 84 |
|
|
2023
Q1 | $471K | Sell |
2,954
-3,837
| -57% | -$612K | 0.31% | 82 |
|
|
2022
Q4 | $1.1M | Sell |
6,791
-512
| -7% | -$82.7K | 0.58% | 38 |
|
|
2022
Q3 | $980K | Buy |
7,303
+231
| +3% | +$31K | 0.66% | 41 |
|
|
2022
Q2 | $1.08M | Buy |
7,072
+454
| +7% | +$69.5K | 0.69% | 38 |
|
|
2022
Q1 | $1.07M | Buy |
6,618
+3,973
| +150% | +$644K | 0.67% | 35 |
|
|
2021
Q4 | $358K | Buy |
+2,645
| New | +$358K | 0.29% | 83 |
|